The Vi capsular polysaccharide vaccine (or ViCPS) is a typhoid vaccine recommended by the World Health Organization for the prevention of typhoid (another... 5 KB (450 words) - 15:09, 27 November 2023 |
 | pneumoniae contained in the vaccine as capsular polysaccharides. It is given by intramuscular or subcutaneous injection. The polysaccharide antigens were used... 15 KB (1,249 words) - 14:09, 27 January 2024 |
 | (TCV), Ty21a (a live oral vaccine) and Vi capsular polysaccharide vaccine (ViPS) (an injectable subunit vaccine). They are about 30 to 70% effective in... 10 KB (855 words) - 04:51, 8 February 2024 |
researched vaccine platform for COVID-19 worldwide was reported to be recombinant protein subunit vaccines. Vi capsular polysaccharide vaccine (ViCPS) against... 67 KB (6,747 words) - 00:37, 12 April 2024 |
 | and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines. They are given by injection either into a muscle... 35 KB (3,344 words) - 03:01, 21 April 2024 |
 | Streptococcus pneumoniae (pneumococcus). It contains purified capsular polysaccharide of pneumococcal serotypes conjugated to a carrier protein to improve... 50 KB (4,208 words) - 01:34, 22 April 2024 |
 | Ty21a (category Drugs that are a vaccine) being the Typhoid Conjugate Vaccine (TCV) and Vi capsular polysaccharide vaccine). The vaccine is given by mouth. The vaccine is presented either as enteric... 6 KB (602 words) - 14:41, 10 September 2023 |
 | Bacterial capsule (redirect from Polysaccharide encapsulated bacteria) different capsular serotypes. These serotypes are the basis for the pneumococcal vaccines. Streptococcus agalactiae produces a polysaccharide capsule of... 17 KB (1,776 words) - 14:46, 3 December 2023 |
serotypes. Whereas effective polysaccharide vaccines have been produced against types A, C, W-135, and Y, the capsular polysaccharide on the type B bacterium... 49 KB (4,270 words) - 05:45, 14 April 2024 |
Chunping; Tan, Yong; Rao, Xiancai; Cong, Yanguang (24 April 2017). "Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi... 40 KB (4,240 words) - 12:21, 20 April 2024 |
NmVac4-A/C/Y/W-135 (category Drugs that are a vaccine) meningitidis, also known as meningococcus. The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup... 24 KB (2,601 words) - 03:15, 15 December 2023 |
 | Group B streptococcal infection (redirect from GBS vaccine) The capsular polysaccharide of GBS, which is an important virulence factor, is also an excellent candidate for the development of an effective vaccine. GBS... 120 KB (14,239 words) - 01:11, 10 March 2024 |
 | Typhoid fever (category Vaccine-preventable diseases) a trivalent vaccine – containing heat-inactivated Typhoid, Paratyphi A and Paratyphi B pathogens. In 1934, discovery of the Vi capsular antigen by Arthur... 96 KB (10,569 words) - 14:31, 27 April 2024 |
 | Meningococcal disease (category Vaccine-preventable diseases) Käyhty H, Densen P (July 1993). "Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late... 45 KB (4,926 words) - 10:11, 5 April 2024 |
 | Institut Pasteur de Dalat (category CS1 Vietnamese-language sources (vi)) Imran; et al. (2010). "Population impact of Vi capsular polysaccharide vaccine". Expert Review of Vaccines. 9 (5): 485–496. doi:10.1586/erv.10.43. PMID 20450323... 10 KB (1,122 words) - 14:33, 16 October 2022 |
 | concentration of anti-pneumococcal capsular polysaccharide antibodies". Vaccine. 25 (19): 3816–26. doi:10.1016/j.vaccine.2007.01.119. PMID 17368878. de Roux... 24 KB (2,229 words) - 01:55, 12 November 2023 |